BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 15707709)

  • 41. Clinical characteristics, diagnosis and management of respiratory distress syndrome in full-term neonates.
    Liu J; Shi Y; Dong JY; Zheng T; Li JY; Lu LL; Liu JJ; Liang J; Zhang H; Feng ZC
    Chin Med J (Engl); 2010 Oct; 123(19):2640-4. PubMed ID: 21034645
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Respiratory function during infancy in survivors of the INNOVO trial.
    Hoo AF; Beardsmore CS; Castle RA; Ranganathan SC; Tomlin K; Field D; Elbourne D; Stocks J;
    Pediatr Pulmonol; 2009 Feb; 44(2):155-61. PubMed ID: 19148936
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhaled nitric oxide in premature infants.
    Ergenekon E
    J Pediatr; 1998 Feb; 132(2):375. PubMed ID: 9506664
    [No Abstract]   [Full Text] [Related]  

  • 44. [Inhaled nitric oxide for newborn infants with severe respiratory failure].
    Gao XR; Wu YQ; Peng XM; Huang M; Liu XH
    Zhongguo Dang Dai Er Ke Za Zhi; 2006 Apr; 8(2):155-7. PubMed ID: 16613714
    [No Abstract]   [Full Text] [Related]  

  • 45. Bronchopulmonary dysplasia and early prophylactic inhaled nitric oxide in preterm infants: current concepts and future research strategies in animal models.
    Rieger-Fackeldey E; Hentschel R
    J Perinat Med; 2008; 36(5):442-7. PubMed ID: 18605970
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adjunct pharmacotherapy in acute lung disease in children.
    Kissoon N; Skippen P
    Minerva Pediatr; 2007 Aug; 59(4):379-88. PubMed ID: 17947843
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Feasibility of nitric oxide administration by neonatal helmet-CPAP: a bench study.
    Trevisanuto D; Doglioni N; Micaglio M; Zanardo V
    Paediatr Anaesth; 2007 Sep; 17(9):851-5. PubMed ID: 17683403
    [TBL] [Abstract][Full Text] [Related]  

  • 48. No definitive recommendation for iNO in preterm infants.
    Schreiber MD; Marks JD
    J Pediatr; 2006 Jul; 149(1):146-7; author reply 147. PubMed ID: 16860152
    [No Abstract]   [Full Text] [Related]  

  • 49. Therapeutic use of nitric oxide in critical settings.
    Braschi A; Iannuzzi M; Belliato M; Iotti GA
    Monaldi Arch Chest Dis; 2001 Apr; 56(2):177-9. PubMed ID: 11499314
    [No Abstract]   [Full Text] [Related]  

  • 50. [The use of nitric oxide during transport of newborns with critical respiratory insufficiency: own experience, preliminary report].
    Ziebiński M; Walas W
    Przegl Lek; 2002; 59 Suppl 1():60-2. PubMed ID: 12108077
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The use of nitric oxide in the treatment of acute respiratory failure].
    Vobruba V; Srnský P; Cerná O; Pokorná P; Kredba V; Sádlo M; Kosut P; Martásek P
    Cas Lek Cesk; 2006; 145(8):639-44; discussion 645-6. PubMed ID: 16995420
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transporting neonates with nitric oxide: the 5-year ShandsCair experience.
    Jesse NM; Drury L; Weiss MD
    Air Med J; 2004; 23(1):17-9. PubMed ID: 14760301
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Predictability model of the need for extracorporeal membrane oxygenation in neonates with meconium aspiration syndrome treated with inhaled nitric oxide.
    Friedlich P; Noori S; Stein J; Shin C; Burns C; Ramanathan R; Seri I
    J Pediatr Surg; 2005 Jul; 40(7):1090-3. PubMed ID: 16034750
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhaled NO and markers of oxidant injury in infants with respiratory failure.
    Van Meurs KP; Cohen TL; Yang G; Somaschini M; Kuruma P; Dennery PA
    J Perinatol; 2005 Jul; 25(7):463-9. PubMed ID: 15889132
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Economic evaluation of inhaled nitric oxide in preterm infants undergoing mechanical ventilation.
    Zupancic JA; Hibbs AM; Palermo L; Truog WE; Cnaan A; Black DM; Ballard PL; Wadlinger SR; Ballard RA;
    Pediatrics; 2009 Nov; 124(5):1325-32. PubMed ID: 19841125
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cost of inhaled nitric oxide therapy in neonates.
    Subhedar NV; Jauhari P; Natarajan R
    Lancet; 2002 May; 359(9319):1781-2. PubMed ID: 12049900
    [No Abstract]   [Full Text] [Related]  

  • 57. Management of respiratory failure in the preterm infant.
    Barrington KJ
    Minerva Pediatr; 2008 Apr; 60(2):183-91. PubMed ID: 18449135
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Preterm and term infants with acute respiratory distress syndrome (ARDS): what is the role of surfactant substitution?].
    Wirbelauer J; Thomas W; Speer CP
    Z Geburtshilfe Neonatol; 2009 Apr; 213(2):33-41. PubMed ID: 19319791
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The use of inhaled nitric oxide in the acute respiratory distress syndrome.
    Young JD
    Br J Hosp Med; 1997 Feb 19-Mar 4; 57(4):126-7. PubMed ID: 9166368
    [No Abstract]   [Full Text] [Related]  

  • 60. Does nitric oxide prevent oxidative mediated lung injury?
    Saugstad OD
    Acta Paediatr; 2000 Aug; 89(8):905-7. PubMed ID: 10976827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.